We are proud to announce that on February 24, 2021, 2:00 PM – 3:30 PM EST Dr. G.E. Ghali, Chancellor for LSU Health Shreveport has been invited to be part of a panel of four people on one of the Town Hall Sessions on the topic of Building Bridges between Public Health and Healthcare Systems to Ensure Equitable Vaccination.
Frequently Asked Questions
- I am sure I could search the internet, but I’d rather trust you. I received the vaccine this week. Is it safe to take a flu vaccine or pneumonia vaccine? How long should I wait in between?
- I recently tested positive and do not know if I still am, but I have no symptoms. Should I wait some period of time before receiving vaccine?
- If I have a question about insurance, who can I talk to?
- I signed up to get the vaccine and I see on Facebook they are all gone? I didn’t get an email to reschedule, I am wondering if I can still come to get the vaccine today.
I am sure I could search the internet, but I’d rather trust you. I received the vaccine this week. Is it safe to take a flu vaccine or pneumonia vaccine? How long should I wait in between?
I recently tested positive and do not know if I still am, but I have no symptoms. Should I wait some period of time before receiving vaccine?
If I have a question about insurance, who can I talk to?
I signed up to get the vaccine and I see on Facebook they are all gone? I didn’t get an email to reschedule, I am wondering if I can still come to get the vaccine today.
GENERAL PUBLIC
LSU Health Shreveport is registering persons who are interested in receiving the COVID-19 vaccine for
pregnant women and residents age 55-64 with qualifying health conditions.
Please complete all the boxes on this link.
REGISTER HERE
While pre-registration is requested, it is not required. Anyone interested in receiving the vaccine should bring their ID and insurance information.
Those under age 65 without a qualifying health condition may also pre-register to receive the vaccine. Appointment times will be emailed once an individual meets the Louisiana Department of Health criteria to receive the vaccine.
EDUCATORS ONLY
LSU Health Shreveport in collaboration with the Louisiana Department of Health Office of Region 7 is offering a vaccine site at 2627 Linwood Avenue for Caddo teachers (public, private and parochial), K-12 support staff, and day care workers.
These specific groups should pre-register at
https://redcap.link/NWLAEducators.
Caddo parish teachers are being informed by Caddo Parish School Board as to whether they will be accessing the vaccine at 2627 Linwood Avenue or another designated site.
Chevyland/LSU Health Shreveport North Campus – 2627 Linwood Avenue – ID, insurance information and proof you are an educator or healthcare worker is required to receive vaccine
Tuesday – Friday, February 23-26 - 2pm- 5pm
Saturday, February 27 - 9am – 4pm
Vaccine Locations This Week!
SHREVEPORT
Louisiana State Fair Grounds
Monday-Friday (Feb. 22-26)
3701 Hudson Drive
8 am – 4 pm
This location is for first and second doses of the vaccine. Appointments within a two hour time block will be emailed no later than Saturday for all those who have pre-registered. Those receiving the second vaccine do NOT need an appointment and are encouraged to come between 8 am and noon when a separate tent/lanes will be available for those getting their second dose.
SHREVEPORT
Galilee Baptist Church
Thursday, February 25
1500 Pierre Street
9 am – 3 pm
This location is for first and second vaccines. No appointment necessary for those receiving their second vaccine.
MINDEN
Tuesday, February 23 (UPDATED)
Webster Parish Fairgrounds
800 Goodwill Drive
10 am to 2pm
This location is for first doses only.
Dr. Matthew Woolard, Assoc. Professor of Microbiology & Immunology says it’s not just enough to know if you have anti-coronavirus antibodies, we need to know how effective they are, and how many are needed to be effective.
< Watch the video to learn more
Vaccine News for LSUHS
Governor John Bel Edwards visited Louisiana’s first mass community vaccine clinic to see firsthand just how well the community effort involving LSU Health Shreveport faculty, students and staff, Region 7 Office of Public Health, Louisiana National Guard, BPCC nursing students, CHRISTUS Shreveport-Bossier Health System and Willis-Knighton Health System is working
Shreveport Times - Dr. John Vanchiere, professor and chief of pediatric infectious diseases at LSUHS, talked about the benefits of getting the vaccine and its safety. “We know that early on when people get infected with COVID-19, most people have no symptoms at all and that is one of the very critical features of this type of infection compared to influenza."
KTBS 3 - “The quicker that people get vaccinated, the less chance of any virus being around and given the opportunity to mutate,” Dr. Ghali, LSU Health Shreveport Chancellor explained. “The longer a virus is around, the longer they're going to be able to mutate. It's a natural course in the development of the virus.”
This week LSU Health Shreveport took a historic step towards stopping the spread of the coronavirus. In addition to continuously testing for COVID-19, the Emerging Viral Threat Lab has now organized the distribution of the vaccine to individuals age 70 and up. On the first day of testing, over 1100 seniors were able to get the vaccine from the safety of their vehicles.
As it relates to COVID, each of us will make a choice about the vaccine. I choose to be vaccinated because I have seen the complications of COVID close up and have great faith in the scientific trials supporting this vaccine.
KSLA 12 - Dr. Robert Rhoads, professor and emeritus chairman of the Department of Biochemistry and Molecular Biology at LSU Health Shreveport, developed key components of the mRNA over years of work. The vaccine uses messenger RNA, or mRNA, which essentially provides instructions to the body on how to fight the novel coronavirus.
KSLA 12 - “It is gratifying to see LSU Health Shreveport’s contributions to the Pfizer-BioNTech vaccine through licensing of a LSUHS patent to BioNTech for mRNA-stabilizing cap analogs and in serving as the only north Louisiana vaccine trial site. Additionally our numerous COVID-19 clinical trials are providing access to novel therapies reflecting the benefit of having an academic medical center in our community,” shared Dr. G.E. Ghali, Chancellor of LSU Health Shreveport.
LSUHS is expanding enrollment in the Pfizer-sponsored COVID-19 vaccine study for the next two weeks to include individuals ages 16-18 and those older than 85 years of age. Those interested in participating in this important vaccine trial should sign up as quickly as possible.
KTBS 3 - LSU Health Shreveport announced this week that it is participating in the Pfizer COVID-19 vaccine study and is currently enrolling people to participate.